Program Spotlight

Building Blocks has designed a preventative home care program for Synagis™ to effectively manage neonates and infants that are at risk for Respiratory Syncytial Virus (RSV) infections.

Synagis™ home injections offers an effective way to administer the drug while ensuring strict compliance. Having the child receive injections in a hospital or clinic may be burdensome for the family, and unnecessarily expose the child to respiratory illnesses.

What is Synagis ?

Through careful monitoring and interventions, children who previously would be admitted to the hospital for RSV infection can be treated preventatively in the home.

The Building Blocks Synagis / RSV Program: